Thermo Fisher Scientific has good revenue and margin growth prospects ahead and is trading at a discount. See why TMO stock ...

Thermo Fisher Scientific has signed an agreement with Mainz Biomed to develop and launch a next-generation colorectal cancer ...

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

Laboratory Products and Services: I project the segment will grow by 9%, in line with historical trends. As such, I calculate Thermo Fisher Scientific’s revenue will grow by 9% organically.

Thermo Fisher Scientific's Q3 revenue of $10.59 billion missed expectations. Adjusted EPS beat estimates but dropped ...

Mainz Biomed (MYNZ) announced a collaborative agreement with Thermo Fisher Scientific (TMO), through its subsidiary ... Mainz Biomed’s Next Generation colorectal cancer screening product. The ...

(Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced a co-marketing and sales agreement with Thermo Fisher Scientific, the world ...

and they were basically flat at its Laboratory and Product Services segment. Thermo Fisher boosted the low end of its full-year adjusted EPS outlook. Shares of Thermo Fisher Scientific (TMO ...

At ASHG, Seer showcased its Proteograph product suite which it claims delivers proteomic ... Seer also announced a ...

On Wednesday, Thermo Fisher Scientific Inc. (NYSE ... Segment revenues increased 4.2% to $1.13 billion, and Laboratory Products and Biopharma Services segment sales were almost flat at $5.74 ...

Thermo Fisher Scientific TMO is preparing to release ... analytical technologies (17% of sales); specialty diagnostic products (10%); life science solutions (23%); and lab products and services ...

We recently made a list of UBS’ Best Stocks In The AI, Growth & Low Rates Era: Top 29 US Stocks. In this piece, we will take ...